Corporate Beneficence and COVID-19

被引:1
|
作者
Ostas, Daniel T. [1 ]
de los Reyes, Gaston [2 ]
机构
[1] Univ Oklahoma, Michael F Price Coll Business, Norman, OK 73072 USA
[2] George Washington Univ, Sch Business, Washington, DC USA
关键词
Beneficence; Adam Smith; social contract theory; corporate responsibility; RESPONSIBILITY; BUSINESS; INSIGHTS; LEGAL;
D O I
10.1177/0971685820973186
中图分类号
C [社会科学总论];
学科分类号
03 ; 0303 ;
摘要
This article explores the motives underlying corporate responses to the COVID-19 pandemic. The analysis begins with Thomas Dunfee's Statement of Minimum Moral Obligation (SMMO), which specifies, more precisely than any other contribution to the business ethics canon, the level of corporate beneficence required during a pandemic. The analysis then turns to Milton Friedman's neoliberal understanding of human nature, critically contrasting it with the notion of stoic virtue that informs the works of Adam Smith. Friedman contends that beneficence should play no role in corporate settings. Smith, by contrast, emphasizes the need for prudence, beneficence and self-command in all human endeavours. The article then uses these competing frameworks to reflect on a published survey of 145 corporate responses to COVID-19. In many of these responses, the benefit to a non-financial stakeholder is clear, while the financial consequence to the firm remains nebulous. This supports the contention that during a pandemic, beneficence provides a more complete explanation of many corporate actions than the profit motive alone. The article contests Friedman's Chicago School profit imperative and goes beyond Dunfee's SMMO by endorsing the more full-throated embrace of beneficence and stoic virtue found in the works of Smith.
引用
收藏
页码:15 / 26
页数:12
相关论文
共 50 条
  • [1] COVID-19 and Corporate Finance
    Pagano, Marco
    Zechner, Josef
    REVIEW OF CORPORATE FINANCE STUDIES, 2022, 11 (04): : 849 - 879
  • [2] Corporate shutdowns in the time of Covid-19
    Bindal, Shradha
    Joseph, Kissan
    Meschke, Felix
    JOURNAL OF CORPORATE FINANCE, 2025, 92
  • [3] Corporate immunity to the COVID-19 pandemic
    Ding, Wenzhi
    Levine, Ross
    Lin, Chen
    Xie, Wensi
    JOURNAL OF FINANCIAL ECONOMICS, 2021, 141 (02) : 802 - 830
  • [4] Corporate leverage during COVID-19
    Huq, Tahsin Imtiazul
    Hassan, M. Kabir
    Tran, Dung Viet
    APPLIED ECONOMICS LETTERS, 2024,
  • [5] IMPACT OF COVID-19 ON CORPORATE CULTURE
    Lorincova, Silvia
    ENTREPRENEURSHIP AND SUSTAINABILITY ISSUES, 2024, 11 (03): : 99 - 117
  • [6] Corporate Resilience and Response to COVID-19
    Cheema-Fox, Alex
    LaPerla, Bridget R.
    Wang, Hui Stacie
    Serafeim, George
    JOURNAL OF APPLIED CORPORATE FINANCE, 2021, 33 (02) : 24 - 40
  • [7] The COVID-19 Pandemic and Corporate Dividend Policy
    Cejnek, Georg
    Randl, Otto
    Zechner, Josef
    JOURNAL OF FINANCIAL AND QUANTITATIVE ANALYSIS, 2021, 56 (07) : 2389 - 2410
  • [8] Corporate governance and COVID-19: a literature review
    Koutoupis, Andreas
    Kyriakogkonas, Panagiotis
    Pazarskis, Michail
    Davidopoulos, Leonidas
    CORPORATE GOVERNANCE-THE INTERNATIONAL JOURNAL OF BUSINESS IN SOCIETY, 2021, 21 (06): : 969 - 982
  • [9] The COVID-19 Pandemic Crisis and Corporate Finance
    Ellul, Andrew
    Erel, Isil
    Rajan, Uday
    REVIEW OF CORPORATE FINANCE STUDIES, 2020, 9 (03): : 421 - 429
  • [10] Female analysts and COVID-19 corporate donation
    Wang, Yang
    Zhang, Yifei
    Kang, Wei
    Ahmed, Ahmed Hassan
    EMERGING MARKETS REVIEW, 2022, 53